Why Zoetis, Akamai, and Seagate Shares Dropped
Zoetis (ZTS) shares fell about 6% to $72.66 after Q2 results, with vet clinical visits down and lower net average selling prices potentially pressuring margins. Akamai (AKAM) traded near the lower end of its $110 to $130 range despite Q2 revenue up 5.8% to $1.1B and $2.8B cloud bookings. Seagate (STX) dropped to $812.76 after Q1 non-GAAP EPS of $5.71 and revenue up 48.8% to $3.63B.
How this was made
The 30-second read
Why it matters
The newest actionable element is the linkage of each stock’s recent weakness to particular Q2 metrics (ZTS visits and ASP risk, AKAM bookings versus selling, STX strong results but profit-taking). However, it does not introduce fresh guidance or new filings beyond the already-referenced Q2 results.
Market read
Traders can use the article as a sentiment read-through from Q2 reactions, but it lacks new disclosures (no guidance, no new filings) to drive a high-conviction trade today.
What to watch
The article does not provide guidance, margin targets, or segment-level profitability details, so traders may be over-weighting visit/ASP commentary without seeing management’s outlook.
Background
The piece is a multi-stock market wrap explaining recent declines by referencing Q2 results and specific operational drivers (pet visits, bookings, and storage earnings).
Ticker impact
Zoetis shares fell nearly 6% after Q2 results, with vet clinical visits down and lower net average selling price pressuring margins.
Choppy to bearish until investors get clearer evidence of visit recovery and margin stabilization.
The article ties the move directly to Q2 outcomes (visits down, ASP risk) rather than a vague market narrative.
Akamai traded at the lower end of its $110 to $130 range despite Q2 revenue up 5.8% and $2.8B cloud infrastructure bookings.
Range-bound with downside risk if investors continue to discount cloud bookings quality or Security growth durability.
The text highlights a specific disconnect: strong bookings and Security growth versus continued selling.
Seagate stock pulled back sharply, closing at $812.76 after posting non-GAAP EPS of $5.71 and revenue up 48.8% Y/Y.
Bearish near-term with potential for a retest of $750 if selling pressure continues.
The $750 retest is speculative and framed as possible if momentum worsens, not a confirmed catalyst.
Market effects
Pet care demand sensitivity to inflation could weigh on pet-health suppliers; cloud security and storage names may face expectation risk even with growth.
No explicit regional driver beyond broad inflation and market reaction framing.
No direct global macro or cross-border policy catalyst cited.
Counterpoint
The selloffs may reflect expectation resets rather than fundamental deterioration, especially for AKAM where Security growth and bookings were still strong.
Key entities
- companyZoetis
Pet drug supplier whose Q2 reaction is tied to falling vet clinical visits and ASP pressure.
- companyAkamai
Cloud infrastructure and security provider whose Q2 revenue and bookings did not prevent selling.
- companySeagate
Hard disk supplier whose strong quarterly revenue and EPS failed to impress markets.
